MINI FUTURE OPTIONSSCHEIN PUT - VERTEX PHARMACEUTICALS

MINI FUTURE OPTIONSSCHEIN PUT - VERTEX PHARMACEUTICALS Share Price

Certificat

DE000DJ6S3Q3

Delayed Deutsche Boerse AG 20:34:59 20/11/2023 GMT
1.27 ^EUR	-33.51%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart VERTEX PHARMACEUTICALS INCORPORATED

Chart MINI FUTURE OPTIONSSCHEIN PUT - VERTEX PHARMACEUTICALS

Latest news about VERTEX PHARMACEUTICALS INCORPORATED

Verve Therapeutics, Inc. Announces Board Appointments	06-28	CI
Redburn Atlantic Initiates Vertex Pharmaceuticals at Buy With $545 Price Target	06-27	MT
Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $500 From $456, Maintains Overweight Rating	06-25	MT
Wells Fargo Adjusts Price Target on Vertex Pharmaceuticals to $555 From $540	06-24	MT

More news

Static data

Product type	Certificat Turbo Stop Loss
Buy / Sell	PUT
Underlying	VERTEX PHARMACEUTICALS INCORPORATED
Issuer	DZ BANK
WKN	DJ6S3Q
ISIN	DE000DJ6S3Q3
Date issued	20/11/2023
Strike	369.4 $
Maturity	Unlimited
Parity	10 : 1
Emission price	2.418 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	1.91 €
Lowest since issue	1.27 €

Company Profile

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).

Sector

More about the company